(Q45088964)

9 December 2017

title

Improved lung function and body mass index associated with long-term use of Macrolide antibiotics (English)

1 reference

9 December 2017

0 references

Omar M Pirzada

1

1 reference

9 December 2017

Jean McGaw

series ordinal

2

1 reference

9 December 2017

Christopher J Taylor

series ordinal

3

1 reference

9 December 2017

Mark L Everard

series ordinal

4

1 reference

9 December 2017

language of work or name

1 reference

1 June 2003

1 reference

Journal of Cystic Fibrosis

9 December 2017

published in

1 reference

9 December 2017

volume

2

1 reference

9 December 2017

issue

2

1 reference

9 December 2017

page(s)

69-71

1 reference

Pathogenesis of cystic fibrosis

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Lung disease in cystic fibrosis--an updated concept

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Diffuse panbronchiolitis and cystic fibrosis: East meets West

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Erythromycin and diffuse panbronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Anti-inflammatory effects of macrolide antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

A pilot study of low-dose erythromycin in bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Long-term azithromycin may improve lung function in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Prediction of Mortality in Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Nutrition and survival in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

Status of gene therapy for cystic fibrosis lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS1569-1993%2803%2900021-3

7 January 2021

10.1016/S1569-1993(03)00021-3

Identifiers

DOI

1 reference

release_v2in77ik5jc3vaodxcphgbnt24

9 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v2in77ik5jc3vaodxcphgbnt24

24 November 2022

mapped directly with Wikidata item

1 reference